Biocon

Viatris Biosimilars is focused on the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology.

Fusion Microfinance, headquartered in New Delhi, focuses on providing financial services to economically disadvantaged women in India, primarily through Joint Liability Groups (JLGs). Established in January 2010, the company expanded its operations by acquiring the microfinance division of Aajeevika, which previously served 1,280 members. Fusion Microfinance specializes in offering small, collateral-free loans, catering to the needs of its clients while also extending lending services to micro, small, and medium enterprises (MSMEs). In addition to its core microfinance activities, the company leverages its distribution network to offer a range of financial products, enabling members to access funds for purchasing productivity-enhancing items such as mobile handsets and bicycles. The company operates primarily in the less penetrated North Central region of India, including Madhya Pradesh, Uttarakhand, Uttar Pradesh, Delhi, and Haryana.

Glympse Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, that specializes in developing modular nanoparticle sensors for noninvasive diagnostics. Founded in 2015, the company focuses on creating diagnostic solutions for various diseases, including fibrosis, cancer, immunology, and infectious diseases. Utilizing a unique platform technology originally developed at MIT, Glympse Bio employs precisely engineered diagnostic agents that interrogate the body to detect specific disease states and transmit this information to urine for analysis. This innovative approach facilitates predictive monitoring and enhances the ability of physicians to assess treatment responses accurately. The company aims to transform disease monitoring and improve patient outcomes through its Glympse Inside product engine, which supports comprehensive, pan-disease diagnostics.